+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease

A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease

Psychosomatics 38(3): 246-252

The objective of this study was to determine the relative efficacy and safety of fluoxetine and amitriptyline in the treatment of major depression complicating Alzheimer's disease (AD). The sample included 37 patients with AD and major depression. The study design was a double-blind, fixed-dose, randomized clinical trial with 45 days of follow-up. The outcome measures were the Hamilton Depression Rating Scale (Ham-D), the Mini-Mental State Exam (MMSE), and the number of dropouts from each arm of the study. Efficacy was similar for fluoxetine and amitriptyline. At Day 45, there was a mean 9.4-point reduction in Ham-D scores (t[df,62] = 9.68, P < 0.0001) and a 2.4-point mean increase in MMSE scores as compared to baseline (t[df,2] = 2.69, P = 0.009). Eleven (58%) of the amitriptyline-treated patients dropped out, compared with 4 (22%) of the fluoxetine-treated patients (chi 2[df,2] = 8.9, P = 0.017). The authors conclude that antidepressant treatment for major depression complicating AD is effective. While fluoxetine and amitriptyline are equally effective, fluoxetine is better tolerated.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 045058467

Download citation: RISBibTeXText

PMID: 9136253

DOI: 10.1016/s0033-3182(97)71461-0

Related references

Randomized, placebo-controlled, crossover, double-blind comparison of immediate- and sustained-release formulations of gallopamil in elderly patients with stable effort angina. Current Therapeutic Research 61(10): 723-741, 2000

Double-blind randomized multicenter study comparing the efficacy and safety of 10-day to 5-day terlipressin treatment of bleeding esophageal varices. Hepato-Gastroenterology 56(90): 390-394, 2009

Fluoxetine treatment of depressed patients with comorbid anxiety disorders. Journal of Psychopharmacology 16(3): 215-219, 2002

Fluoxetine and involuntary recall of remote memories. Australian and New Zealand Journal of Psychiatry 31(1): 128-130, 1997

Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion. European Neuropsychopharmacology. 6(3): 163-168, 1996

A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension. Acta Cardiologica 52(6): 495-506, 1997

A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo. La Clinica Terapeutica 120(2): 111-118, 1987

A randomized, double-blind comparison of the effects of interpleural bupivacaine and saline on morphine requirements and pulmonary function after cholecystectomy. Anesthesiology 71(3): 339-343, 1989

Is antithyroid treatment really relevant for young patients with subclinical hyperthyroidism?. Endocrine Journal 49(3): 307-314, 2002

Double-blind, placebo-controlled, cross-over trial of progabide as add-on therapy in epileptic patients. Epilepsia 32(1): 133-139, 1991

Efficacy and safety of drug-eluting stents in patients with chronic kidney disease. Cardiovascular Revascularization Medicine 10(3): 200-201, 2009

Efficacy and safety of drugs for Pagets disease of bone. Bone (new York). 17(5 Suppl.): 485s-488s, 1995

Comparison of minitrampoline- and full-sized trampoline-related injuries in the United States, 1990-2002. Pediatrics 116(1): 96-103, 2005

Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer A randomised trial. Lancet (north American Edition). 355(9215): 1588-1596, 2000

The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues. Growth Hormone and Igf Research 11(3): 173-186, 2001